Inventor
WILLIAMS CLAIRE
GB12 patents
⚠️ This page may combine multiple inventors who share the name “WILLIAMS CLAIRE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GW PHARMA LTD
5 patentsUS9522123B2Dec 20, 2016
Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy
GW PHARMA LTD62 citations98
US11318109B2May 3, 2022
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
GW PHARMA LTD17 citations94
US10799467B2Oct 13, 2020
Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy
GW PHARMA LTD22 citations92
US12023305B2Jul 2, 2024
Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy
GW PHARMA LTD9 citations84
US12121499B2Oct 22, 2024
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
GW PHARMA LTD3 citations74
WHALLEY BEN
2 patentsGW RES LTD
2 patentsUS11793770B2Oct 24, 2023
7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsy
GW RES LTD18 citations93
US11147776B2Oct 19, 2021
7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsy
GW RES LTD33 citations93
JAZZ PHARMACEUTICALS RESEARCH UK LTD
2 patentsUS12357586B2Jul 15, 2025
Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
JAZZ PHARMACEUTICALS RESEARCH UK LTD2 citations74
US12263139B2Apr 1, 2025
Use of cannabidiol in the treatment of tuberous sclerosis complex
JAZZ PHARMACEUTICALS RESEARCH UK LTD2 citations64